financetom
Business
financetom
/
Business
/
Mitek Systems Fiscal Q4 Adjusted Earnings Fall, Revenue Rises; Q1 Guidance Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mitek Systems Fiscal Q4 Adjusted Earnings Fall, Revenue Rises; Q1 Guidance Set
Mar 10, 2026 10:15 PM

04:30 PM EST, 12/11/2025 (MT Newswires) -- Mitek Systems ( MITK ) reported fiscal Q4 adjusted earnings late Thursday of $0.24 per diluted share, down from $0.33 a year earlier.

Analysts polled by FactSet expected $0.18.

Revenue for the three months ended Sept. 30 was $44.8 million, up from $43.2 million a year earlier.

Analysts surveyed by FactSet expected $40.9 million.

For fiscal Q1, the company expects revenue of $41 million to $44 million. Analysts expect $41.1 million.

The company expects full-year fiscal 2026 revenue of $185 million to $195 million. Analysts expect $190 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EHang Holdings' Pilotless Electric Vertical Take-Off and Landing Aircraft Gets Approval for Test Flights in Brazil
EHang Holdings' Pilotless Electric Vertical Take-Off and Landing Aircraft Gets Approval for Test Flights in Brazil
Sep 16, 2024
10:40 AM EDT, 09/16/2024 (MT Newswires) -- EHang Holdings ( EH ) said Monday it has received an experimental flight authorization certificate from Brazil's National Civil Aviation Agency for its EH216-S pilotless electric vertical take-off and landing aircraft system. The company and its local partner and operator Gohobby plan to conduct test and trial flights for the aircraft in Brazil,...
Poseida Gets Regenerative Medicine Advanced Therapy Designation for Myeloma Treatment; Shares Rise
Poseida Gets Regenerative Medicine Advanced Therapy Designation for Myeloma Treatment; Shares Rise
Sep 16, 2024
10:42 AM EDT, 09/16/2024 (MT Newswires) -- Poseida Therapeutics ( PSTX ) said Monday the US Food and Drug Administration granted regenerative medicine advanced therapy designation to the experimental P-BCMA-ALLO1 therapy in phase 1/1b clinical development to treat relapsed or refractory multiple myeloma, a type of cancer. The designation encompasses all the advantages of the fast track and breakthrough therapy...
Alibaba, NIO, Other Chinese Stocks On Watch Following Weak Economic Data: What To Know
Alibaba, NIO, Other Chinese Stocks On Watch Following Weak Economic Data: What To Know
Sep 16, 2024
US-listed shares of Chinese stocks, including Alibaba Group Holding Limited ( BABA ) and PDD Holdings, Inc. ( PDD ) , are trading slightly lower Monday following weak economic data released over the weekend. The Details: Data released on Saturday showed factory output, consumption and investment in China all slowed more than anticipated, while the jobless rate unexpectedly rose to...
Healthy Choice Wellness Prices $4 Million IPO; Completes Spinoff From Healthier Choices Management
Healthy Choice Wellness Prices $4 Million IPO; Completes Spinoff From Healthier Choices Management
Sep 16, 2024
10:42 AM EDT, 09/16/2024 (MT Newswires) -- Healthy Choice Wellness said Monday that it priced its initial public offering of 400,000 class A common shares at $10 apiece for gross proceeds of $4 million and completed its spinoff from Healthier Choices Management. Underwriters have a 45-day option to buy up to an additional 60,000 Class A shares to cover over-allotments,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved